-
1 Comment
Baotou Dongbao Bio-Tech Co.,Ltd is currently in a long term downtrend where the price is trading 2.3% below its 200 day moving average.
From a valuation standpoint, the stock is 28.4% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 6.9.
Baotou Dongbao Bio-Tech Co.,Ltd's total revenue rose by 5.7% to $114M since the same quarter in the previous year.
Its net income has dropped by 39.0% to $4M since the same quarter in the previous year.
Finally, its free cash flow grew by 5.8% to $-55M since the same quarter in the previous year.
Based on the above factors, Baotou Dongbao Bio-Tech Co.,Ltd gets an overall score of 3/5.
Sector | Healthcare |
---|---|
Industry | Drug Manufacturers - Specialty & Generic |
ISIN | CNE100001583 |
Exchange | SHE |
CurrencyCode | CNY |
Beta | 0.1 |
---|---|
PE Ratio | 36.5 |
Target Price | None |
Dividend Yield | 0.4% |
Market Cap | 3B |
Baotou Dongbao Bio-Tech Co.,Ltd engages in the research and development, production, and sale of gelatin, collagen, and additional products in the People's Republic of China and internationally. It offers gelatin for jelly, confection, yogurt, plasma substitute, tablets, softgel, photographic paper, and hard capsules; plasma gelatin substitute, hollow capsule, double protein dietary fiber, cosmetics, and other products; agglomerated collagen peptide; hydrolyzed collagen power and granule; collagen peptide power and granule; hydrolyzed fish collagen; collagen jars; and fish collagen peptide powder, as well as food additive and pharmaceutical gelatin. The company also engages in research and development, production, and sale of bio-organic fertilizers, including industrial and feed grade calcium hydrogen phosphate; inorganic and organic microorganisms fertilizers; nitrogen fertilizers; calcium amino acid fertilizer; bone-derived biological calcium fertilizer; and biological and refined organic fertilizer. In addition, it is involved in the research and development, production, and sale of empty capsules. The company was founded in 1960 and is based in Baotou, the People's Republic of China.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for 300239.SHE using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025